Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	2.71M 2.36M 2.23M 2.02M 3.79M 260M 3.81M 26.7M 10.3M 132M 10.17M 9.94M 425M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.19M 10.56M 9.59M 17.97M 1.23B 18.04M 127M 48.82M 626M 48.19M 47.12M 2.01B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
10/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
10/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
10/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
07/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
07/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
07/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
07/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	Avinger : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
07/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	04/08/2024

Avinger Inc Share Price Nasdaq

Stocks

US0537341093

Advanced Medical Equipment & Technology

Valuation: Avinger Inc

Latest news: Avinger Inc

Analysts' recommendations: Avinger Inc

Press Releases: Avinger Inc

Quotes and Performance

Managers and Directors: Avinger Inc

Medical Imaging Systems

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER INC	-3.55%	-6.61%	-	-	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+0.70%	-2.05%	-31.71%	-4.72%	12.32B
IRAY GROUP	+0.74%	+3.06%	+13.39%	+5.19%	4.27B
SONOSCAPE MEDICAL CORP.	+2.43%	-1.35%	-44.85%	-60.48%	1.2B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+2.10%	-0.20%	-42.48%	-44.99%	1.06B
IRADIMED CORPORATION	-0.75%	-0.12%	+16.45%	+80.60%	1.05B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+3.85%	+6.56%	-36.79%	-	1.02B
NINGBO JANSEN SUPERCONDUCTING TECHNOLOGIES CO., LTD.	+2.69%	+5.06%	-	-	1B
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+3.03%	+5.92%	+37.90%	+107.36%	518M
CAPSOVISION, INC.	+5.85%	+1.52%	+41.35%	-	335M
Average	+1.71%	+1.65%	-5.84%	+13.83%	2.53B
Weighted average by Cap.	+1.15%	+0.39%	-19.25%	-0.78%

	2022	2023
Net sales	8.27M 7.21M 6.81M 6.19M 11.59M 794M 11.64M 81.59M 31.49M 404M 31.08M 30.39M 1.3B	7.65M 6.67M 6.3M 5.72M 10.72M 734M 10.76M 75.47M 29.12M 373M 28.74M 28.11M 1.2B
Net income	-17.62M -15.37M -14.51M -13.18M -24.69M -1.69B -24.79M -174M -67.07M -860M -66.2M -64.73M -2.77B	-18.32M -15.98M -15.08M -13.7M -25.66M -1.76B -25.77M -181M -69.73M -894M -68.82M -67.29M -2.88B
Net Debt	1.76M 1.53M 1.45M 1.31M 2.46M 168M 2.47M 17.32M 6.68M 85.67M 6.6M 6.45M 276M	10.12M 8.82M 8.33M 7.57M 14.18M 971M 14.24M 99.81M 38.52M 494M 38.02M 37.17M 1.59B